latest news in investor scrutiny

Zimmer Biomet Faces Investor Concerns Over Revenue Forecast

Zimmer Biomet Faces Investor Concerns Over Revenue Forecast

San Francisco, Tuesday, 18 November 2025.
Zimmer Biomet Holdings is under scrutiny after emerging markets faced distributor order cancellations, leading to a reduced revenue forecast and a 15% drop in share price.